PHARMENG LTDActive
Key figures
PHARMENG LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2021–2025
| 2021 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Turnover | 6,921,643 | 13,365,665 | 9,972,717 | — |
| Profit for the year | 156,099 | 308,057 | 11,730 | -1,075,816 |
| Cash at bank and in hand | 0 | 188,093 | 122,392 | 255,904 |
| Total assets | 1,679,824 | 2,706,072 | 4,197,276 | 1,612,980 |
| Total liabilities | — | — | — | — |
| Net assets / total equity | 329,323 | 1,048,964 | 1,060,694 | -15,122 |
| Average number of employees | 453 | 935 | 473 | 351 |
| Average pay (per year) | 4,768 | 3,725 | 5,977 | 8,007 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company in the year under review is the provision of specialist staff to all industries.
As described in the company's latest filed accounts.
Summary: PHARMENG LTD
Company
PHARMENG LTD is a private limited company registered with Companies House under company number 08258301. It was incorporated on 18 Oct 2012. Its status is active. The registered office is in London (EC4N). Its nature of business (SIC 2007) is other activities of employment placement agencies (78109).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Loss for the year was £1,075,816. Net assets were −£15,122, down 101.4% on the previous year. Cash at bank and in hand was £255,904. The company had an average of 351 employees. Figures are available for 4 financial years (2021–2025).
Control and charges
2 persons with significant control are registered. 4 of 8 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 20 Oct 2026.